Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Antibody-mediated Transplant Rejection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02426684
What this trial is testing

Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation

Who this might be right for
Renal Disease
Cedars-Sinai Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT03380377
What this trial is testing

Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant

Who this might be right for
Antibody-mediated RejectionKidney Transplant; ComplicationsTransplant Glomerulopathy+3 more
Stanley Jordan, MD 10
Post-approval studies (Phase 4)Looking for participantsNCT07689578
What this trial is testing

Safety and Efficacy of the Bispecific T-Cell Engager (BiTE) in Kidney Transplant Recipients With Chronic Active Antibody-Mediated Rejection

Who this might be right for
Antibody Mediated Rejection After Kidney Transplantation
Turun Song 50
Large-scale testing (Phase 3)Ended earlyNCT03744910
What this trial is testing

Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
CSL Behring 194
Post-approval studies (Phase 4)Ended earlyNCT02546492
What this trial is testing

Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar

Who this might be right for
Transplant Glomerulopathy
University of Maryland, Baltimore 6
Not applicableLooking for participantsNCT04870437
What this trial is testing

Impact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocytes During Chronic AntiBody-Mediated Rejection in Kidney Transplantation.

Who this might be right for
Kidney Transplantation
University Hospital, Angers 30
Not applicableUnknownNCT03436134
What this trial is testing

Treatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis or Plasma Exchange

Who this might be right for
Kidney TransplantationAntibody Mediated Rejection
University Hospital, Grenoble 16
Testing effectiveness (Phase 2)Study completedNCT02201576
What this trial is testing

Bortezomib in Rejection of Kidney Transplants

Who this might be right for
Chronic Antibody-mediated Transplant Rejection
Assistance Publique - Hôpitaux de Paris 60
Not applicableStudy completedNCT04367610
What this trial is testing

Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection

Who this might be right for
Antibody-mediated RejectionKidney Transplant RejectionGraft Loss
Istanbul University 75
Large-scale testing (Phase 3)Enrolling By InvitationNCT06801886
What this trial is testing

Silymarin's Advantage on Graft Effectiveness

Who this might be right for
Posttransplant Diabetes MellitusAcute Graft RejectionBiopsy Proven Acute Rejection+2 more
University Hospital, Martin 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT03991780
What this trial is testing

Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection

Who this might be right for
Renal Transplant Rejection
Imperial College London 8
Not applicableLooking for participantsNCT07006532
What this trial is testing

Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab

Who this might be right for
Kidney Transplant Rejection
Shahid Beheshti University of Medical Sciences 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06886646
What this trial is testing

Allogeneic Umbilical Cord Mesenchymal Stromal Cells for the Treatment of Chronic Antibody-Mediated Rejection in Kidney Transplantation

Who this might be right for
Chronic Antibody-mediated Rejection (cABMR)
Assistance Publique - Hôpitaux de Paris 22